Endothelial and platelet-derived extracellular vesicles dynamically reflect the state of their parent cells, serving as promising diagnostic and prognostic biomarkers in cardiovascular diseases.
Extracellular vesicles (EVs) are membrane-bound structures released by all cell types. They play a critical role in intercellular communication by transferring their cargo, comprising proteins, lipids, metabolites, RNAs, miRNAs, and DNA fragments, to recipient cells. This transfer influences gene expression, signaling pathways, and cellular behavior. Due to their ability to alter the physiology of recipient cells, EVs hold significant therapeutic potential. Additionally, EVs are implicated in various physiological and pathological processes, including immune regulation, cancer progression, and cardiovascular diseases. EVs have been detected in many biological fluids, such as peripheral blood, saliva, urine, cerebrospinal fluid, and breast milk. The cargo of EVs dynamically reflects the physiological and pathological state of their parent cells, making them promising candidates for liquid biopsies in various clinical conditions. Specifically, different EV subtypes in cardiovascular diseases have been studied, with both endothelial and platelet-derived EVs playing significant roles in cardiovascular pathologies. This review focuses on the diagnostic and prognostic potential of endothelial and platelet-derived EVs in cardiovascular diseases, highlighting the role of EV subpopulations.
Febo et al. (Fri,) conducted a review in Cardiovascular diseases. Endothelial- and platelet-derived extracellular vesicles was evaluated. Endothelial and platelet-derived extracellular vesicles dynamically reflect the state of their parent cells, serving as promising diagnostic and prognostic biomarkers in cardiovascular diseases.